Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | McElrath: Innate to Adaptive Immunity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-03-09 |
| Study Made Public: | 2016-10-21 |
Title
Evaluating the impact in nonhuman primates of using nano particle formulated TLR 4 and 7 agonists for enhancing humoral immunity against HIV specific envelope protein immunogens - a study conducted by the Pulandran laboratory
Description
CAVD 355 (CAVIMC-045) is a non-human primate study of protein and adjuvant regimens.
Sign in to see full information about this study and to download study data.
Products
HIV-1 CN54 gp140 SIV p55 gag PLGA (MPL) PLGA (R848)Integrated data
BAMA, NAb
Non-integrated data
No non-integrated data is available for this study.